|Publication number||US5312550 A|
|Application number||US 07/873,781|
|Publication date||May 17, 1994|
|Filing date||Apr 27, 1992|
|Priority date||Apr 27, 1992|
|Publication number||07873781, 873781, US 5312550 A, US 5312550A, US-A-5312550, US5312550 A, US5312550A|
|Inventors||Robert L. Hester|
|Original Assignee||Hester Robert L|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (6), Referenced by (86), Classifications (11), Legal Events (11) |
|External Links: USPTO, USPTO Assignment, Espacenet|
Method for detecting undesired dialysis recirculation
US 5312550 A
In a dialysis system wherein blood is removed from a patient's vascular system and passed through a dialyzer system comprising an inlet arterial line, a dialyzer, and an outlet venous line, the blood being fed via the inlet arterial line to the dialyzer and returned to the patient via the outlet venous line, a material having a physical property differing from that of blood is injected at a point in the venous return line. The fluid in the dialysis system upstream from the injection point is monitored for the presence of the different physical property whereby direct recirculation from the venous return line to the arterial intake line is detected.
1. In a dialysis process wherein blood is removed from a patient's vascular system and passed through a dialyzer system comprising an inlet arterial line, a dialyzer, and an outlet venous line, said blood being fed via said inlet arterial line to said dialyzer and returned to the patient via said outlet venous line, the improvement comprising:
(a) injecting a material at an injection point in said dialyzer system, said material having a physical property differing from that of blood; and
(b) monitoring the fluid in said dialyzer system at a point in said dialyzer system upstream from said injection point for the presence of said differing physical property, to thereby detect undesired recirculation of freshly dialyzed blood from said venous line directly to said arterial line.
2. The process defined in claim 1, wherein said material is a saline solution substantially isotonic with blood.
3. The process defined in claim 2, wherein said step of monitoring comprises measuring the optical density of said fluid.
4. The process defined in claim 1, wherein said step of monitoring comprises measuring the optical density of said fluid.
5. The proces defined in claim 1, wherein said injection point is in said venous line.
The invention relates to the field of kidney dialysis processes, and more particularly to such processes for detecting undesirable recirculation of the dialyzed blood.
Dialysis is a process by which an artificial kidney replaces the function of a patient's kidney. Blood is removed from the patient's vascular system via an arterial line, passed through a dialyzer, and returned to the patient via a venous line for normal circulation through the patient's vascular system. A majority of patients have an arterial-venular shunt implanted to accommodate the high rate of blood flow, which typically is about 350 ml/minute. However, if there is a problem with the venous outflow, freshly dialyzed blood returning to the patient via the venous line can pass upstream through the shunt and return directly to the arterial line where it is again filtered. If this undesired direct recirculation level is high enough, a small amount of blood is repeatedly refiltered and the rest of the patient's blood is not sufficiently filtered to provide the patient with adequate dialysis.
The standard test for undesired direct recirculation requires three blood samples while the patient is on dialysis. This method of determining recirculation requires blood samples from the patient, technical time from the nurses, and high laboratory costs. Dialysis patients have lower hematocrit than the normal population, and thus cannot afford to lose blood.
These and other problems with prior art practice are avoided by the present invention, which provides an accurate determination of undesired recirculation at lower cost.
According to a principal aspect of the invention, there is provided in a dialysis process wherein blood is removed from a patient's vascular system and passed through a dialyzer system comprising an inlet arterial line, a dialyzer, and an outlet venous line, the blood being fed via the inlet arterial line to the dialyzer and returned to the patient via the outlet venous line, the improvement comprising injecting a material at an injection point in the dialyzer system, the material having a physical property differing from that of blood, and monitoring the fluid in the dialyzer system at a point upstream from the injection point for the presence of the differing physical property, to thereby detect undesired recirculation of freshly dialyzed blood from the venous line directly to the arterial line.
According to another aspect of the invention, the material is a saline solution substantially isotonic with blood.
According to another aspect of the invention, the step of monitoring comprises measuring the optical density of the fluid.
Other aspects will in part appear hereinafter and will in part be apparent from the following detailed description taken together with the accompanying drawings, wherein:
FIG. 1 is a schematic elevation view of the prior art; and
FIG. 2 is a similar schematic elevation view of the preferred embodiment of the present invention.
Referring to FIG. 1, blood is removed from upstream location 20 in blood vessel 22 and passed through arterial line 24 to a non-illustrated dialyzer, then returned from the dialyzer via venous line 26 ,to downstream location 28 in vessel 22. Vessel 22 is illustrated as an arterial-venular shunt connected at its upstream end to artery 30 and connected at its downstream end to a non-illustrated downstream blood vein. If the downstream vein presents an unduly high resistance to the outflow of dialyzed blood issuing from venous line 26, part of the freshly dialyzed blood will flow back to upstream location 20 as indicated by arrow 31, and will be returned via line 24 to the dialyzer.
To prevent such undesired recirculation, current practice is to remove a blood sample from artery 30, another from sampling port 32, and a third from sampling port 34. These samples are then chemically analyzed to determine the amounts of certain constituent chemicals contained therein, from which the degree of undesired recirculation, if any, may be calculated. These chemical analyses are costly and time consuming. On occasion, dialysis is completed before the analyses determine that excessive undesired recirculation has occurred. In such an instance, some hours of dialysis have done the patient little good.
The preferred embodiment of the present invention is illustrated in FIG. 2. As illustrated therein, a material having a selected physical property differing from that of blood is injected into venous line 26 through injection port 36. In the preferred embodiment, this material is a saline solution isotonic with blood. Such a saline solution differs from blood in color, and the amount of saline solution intermixed with blood can readily be determined optically. Accordingly, a detector is provided at a location upstream of injection port 36, preferably as illustrated in line 24. The detection comprises light source 42 shining light through the fluid passing through line 24, and photodetector 44 produces an output signal related to the optical density of the fluid. The output signal is fed to computer 46 where it is analyzed.
Injection of 10 ml. of saline dilutes the freshly dialyzed blood flowing through venous line 26, making it more transparent. If there is direct recirculation from location 28 to location 20, some of the saline solution will be carried into arterial line 24, resulting in an increase in light intensity detected by photodetector 44 and a resulting change in the output signal produced thereby.
With this method of determining the presence and amount of recirculation, no blood is taken from the patient, the results are known in minutes rather than hours, and costs are substantially reduced.
While the above example uses an isotonic saline solution, other materials and other physical properties than optical properties may be used.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US3482575 *||Feb 16, 1967||Dec 9, 1969||Single Cell Research Foundatio||Method for the extracorporeal oxygenation of blood|
|US3619423 *||Apr 20, 1970||Nov 9, 1971||Us Health Education & Welfare||Cascade dialysis apparatus and method|
|US4181610 *||Jul 8, 1976||Jan 1, 1980||Takeda Chemical Industries, Ltd.||Light-emitting diodes|
|US5092836 *||Mar 19, 1990||Mar 3, 1992||Fresenius Ag||Hemodialysis apparatus with automatic adjustment of dialysis solution flow|
|SU521891A1 *|| ||Title not available|
|SU1013853A1 *|| ||Title not available|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US5453576 *||Oct 24, 1994||Sep 26, 1995||Transonic Systems Inc.||FOr measuring blood parameters|
|US5510716 *||Nov 1, 1994||Apr 23, 1996||Cobe Laboratories, Inc.||Differential conductivity recirculation monitor|
|US5510717 *||May 31, 1995||Apr 23, 1996||Cobe Laboratories, Inc.||Differential conductivity recirculation monitor|
|US5570026 *||May 31, 1995||Oct 29, 1996||Cobe Laboratories, Inc.||Altered fluid conductivity monitor|
|US5595182 *||Jun 7, 1995||Jan 21, 1997||Transonic Systems, Inc.||Cardiovascular measurements by sound velocity dilution|
|US5631552 *||Jun 7, 1995||May 20, 1997||Cobe Laboratories, Inc.||Hemodynamic monitor for detecting air bubbles|
|US5685989 *||Sep 16, 1994||Nov 11, 1997||Transonic Systems, Inc.||Method and apparatus to measure blood flow and recirculation in hemodialysis shunts|
|US5813408 *||Sep 15, 1995||Sep 29, 1998||Boston Scientific Technology, Inc.||Surgical drape|
|US5830365 *||Jul 25, 1996||Nov 3, 1998||Fresenius Ag||Means for determining hemodynamic parameters during extracorporeal blood treatment|
|US5866015 *||Nov 7, 1996||Feb 2, 1999||Fresenius Ag||Method for determining hemodynamic parameters during an extracorporeal hemotherapy and related device|
|US5900726 *||Jun 16, 1997||May 4, 1999||Cobe Laboratories, Inc.||For determining a fluid flow parameter of blood|
|US6075367 *||Dec 23, 1998||Jun 13, 2000||Gambro, Inc.||Differential conductivity hemodynamic monitor|
|US6117099 *||Dec 3, 1997||Sep 12, 2000||In-Line Diagnostics Corporation||System and method for noninvasive hemodynamic measurements in hemodialysis shunts|
|US6153109 *||Jan 22, 1998||Nov 28, 2000||Transonic Systmes, Inc.||Method and apparatus to measure blood flow rate in hemodialysis shunts|
|US6167765||Sep 25, 1998||Jan 2, 2001||The Regents Of The University Of Michigan||System and method for determining the flow rate of blood in a vessel using doppler frequency signals|
|US6189388||Nov 12, 1997||Feb 20, 2001||Gambro, Inc.||Access flow monitoring using reversal of normal blood flow|
|US6210591||Jul 2, 1999||Apr 3, 2001||Transonic Systems, Inc.||Method to measure blood flow rate in hemodialysis shunts|
|US6452371||May 2, 2000||Sep 17, 2002||Gambro, Inc.||Differential conductivity hemodynamic monitor|
|US6468241||Oct 26, 2000||Oct 22, 2002||Chf Solutions, Inc.||Disposable cartridge for filtration of blood|
|US6533747||Oct 30, 2000||Mar 18, 2003||Chf Solutions, Inc.||Extracorporeal circuit for peripheral vein fluid removal|
|US6537240||Oct 17, 1997||Mar 25, 2003||Hospal Ag||Method for determining the recirculation of blood in a vascular access and a system for implementing same|
|US6575927||May 12, 1999||Jun 10, 2003||The Regents Of The University Of Michigan||System and method for determining blood flow rate in a vessel|
|US6582656||Mar 28, 2000||Jun 24, 2003||In-Line Diagnostics Corporation||System and method for noninvasive hemodynamic measurements in hemodialysis shunts|
|US6585675||Nov 2, 2000||Jul 1, 2003||Chf Solutions, Inc.||Method and apparatus for blood withdrawal and infusion using a pressure controller|
|US6614212||Sep 10, 2002||Sep 2, 2003||Gambro, Inc.||Differential conductivity hemodynamic monitor|
|US6648845||Jan 7, 1998||Nov 18, 2003||Fresenius Medical Care North America||Calculating blood access flow rate based on sodium or urea concentration measurements|
|US6689083||Nov 27, 2000||Feb 10, 2004||Chf Solutions, Inc.||Fluid removal from overloaded patient; filter permeable to water and electrolyes but not blood protein; kidney dialysis|
|US6695806||Oct 17, 2002||Feb 24, 2004||Chf Solutions, Inc.||Artificial kidney set with electronic key|
|US6706007||Dec 29, 2000||Mar 16, 2004||Chf Solutions, Inc.||Feedback control of ultrafiltration to prevent hypotension|
|US6709414||Feb 21, 2003||Mar 23, 2004||The Regents Of The University Of Michigan||Hemodialysis access; ultrasonic sensor|
|US6726647||Oct 22, 1999||Apr 27, 2004||Gambro Ab||Arterial needle removes blood from the access to an extracorporeal circuit comprising a dialyzer and a venous needle returns the blood to the access site|
|US6740036||Oct 18, 2002||May 25, 2004||Lian-Pin Lee||Optical and ultrasound probe for monitoring blood volume changes|
|US6773412||Apr 13, 2001||Aug 10, 2004||Chf Solutions, Inc.||Detecting and displaying the location of a leakage, blockage, or air bubble in dialysis line|
|US6796955||Feb 14, 2002||Sep 28, 2004||Chf Solutions, Inc.||For use in procedures such as ultrafiltration, apheresis and dialysis; discriminates between minor occlusions that can be cured automatically or by prompting the patient to take corrective action, and more serious problems|
|US6868739||Oct 19, 1999||Mar 22, 2005||Transonic Systems, Inc.||Method and apparatus to measure blood flow by an introduced volume change|
|US6887214||Sep 12, 2000||May 3, 2005||Chf Solutions, Inc.||Blood pump having a disposable blood passage cartridge with integrated pressure sensors|
|US6890315||Jul 18, 2000||May 10, 2005||Chf Solutions, Inc.||Condensing withdrawn blood through a filter to separate the excess water from the blood, before returning to patient|
|US6912917||Jul 29, 2003||Jul 5, 2005||Gambro, Inc.||Differential fluid parameter determination|
|US6923782||Aug 19, 2003||Aug 2, 2005||Chf Solutions, Inc.||User interface for blood treatment device|
|US7097630||Feb 27, 2003||Aug 29, 2006||Fresenius Medical Care North America||Method and apparatus for determining hemodialysis parameters|
|US7121150||Mar 18, 2005||Oct 17, 2006||Transonic Systems, Inc.||Method and apparatus to determine an initial flow rate in a conduit|
|US7172570||Jan 28, 2004||Feb 6, 2007||Gambro Lundia Ab||Apparatus and method for monitoring a vascular access of a patient subjected to an extracorporeal blood treatment|
|US7175809||Mar 16, 2004||Feb 13, 2007||Chf Solutions Inc.||Feedback control of ultrafiltration to prevent hypotension|
|US7297280||Jun 18, 2004||Nov 20, 2007||Transonic Systems, Inc.||Method and apparatus to measure blood flow in hemodialysis shunts|
|US7303540||Apr 26, 2004||Dec 4, 2007||Chf Solutions, Inc.||User interface for blood treatment device|
|US7311689||Aug 19, 2003||Dec 25, 2007||Chf Solutions, Inc.||Method and apparatus for peripheral vein fluid removal in heart failure|
|US7399289||Aug 27, 2003||Jul 15, 2008||Chf Solutions, Inc.||Controller for ultrafiltration blood circuit which prevents hypotension by monitoring osmotic pressure in blood|
|US7410473||Apr 26, 2005||Aug 12, 2008||Chf Solutions Inc.||Blood pump having a disposable blood filter with integrated pressure sensors|
|US7462161||Jun 17, 2005||Dec 9, 2008||Chf Solutions, Inc.||Method and apparatus for blood withdrawal and infusion using a pressure controller|
|US7473371||Apr 13, 2005||Jan 6, 2009||Transonic Systems, Inc.||Measurement of a blood flow rate in hemodialysis shunts|
|US7500958||Feb 27, 2004||Mar 10, 2009||Gambro Lundia Ab||Switch valve for an extracorporeal blood circuit and circuit including such a switch valve|
|US7540851||Jul 27, 2004||Jun 2, 2009||Chf Solutions, Inc.||Method to control blood and filtrate flowing through an extracorporeal device|
|US7585286||Dec 3, 2007||Sep 8, 2009||Chf Solutions, Inc.||User interface for blood treatment device|
|US7647834||Aug 1, 2005||Jan 19, 2010||Chf Solutions Inc.||Pressure sensor disconnect detection for a blood treatment device|
|US7674236 *||Oct 15, 2005||Mar 9, 2010||Fresenius Medical Care Deutschland Gmbh||Device and method for detecting complications during an extracorporeal blood treatment|
|US7674237||Jun 24, 2003||Mar 9, 2010||Chf Solutions, Inc.||Method and apparatus for blood withdrawal and infusion using a pressure controller|
|US7749184||Dec 20, 2006||Jul 6, 2010||Gambro Lundia Ab||Apparatus and method of monitoring a vascular access of a patient subjected to an extracorporeal blood treatment|
|US7794419||May 18, 2005||Sep 14, 2010||Gambro Lundia Ab||Apparatus for controlling blood flow in an extracorporeal circuit|
|US7815852||Nov 18, 2004||Oct 19, 2010||Gambro Lundia Ab||Method, apparatus and software program for measurement of a parameter relating to a heart-lung system of a mammal|
|US7836914||Dec 10, 2004||Nov 23, 2010||Gambro Lundia Ab||Switching device and apparatus for controlling flow of a fluid|
|US7886611||Jan 15, 2010||Feb 15, 2011||Chf Solutions Inc.||Pressure sensor disconnect detection for a blood treatment device|
|US7896831||Mar 6, 2009||Mar 1, 2011||Gambro Lundia Ab||Method and apparatus for calculating fluid flow rate|
|US7935071||Dec 19, 2007||May 3, 2011||Chf Solutions, Inc.||Method and apparatus for peripheral vein fluid removal in heart failure|
|US7955289||Dec 8, 2008||Jun 7, 2011||Chf Solutions, Inc.||Method and apparatus for blood withdrawal and infusion using a pressure controller|
|US7955291||Aug 27, 2009||Jun 7, 2011||Gambro Lundia Ab||Method and apparatus for detecting access recirculation|
|US8197432||Sep 3, 2009||Jun 12, 2012||Gambro Uf Solutions, Inc.||User interface for blood treatment device|
|US8328749 *||Oct 11, 2006||Dec 11, 2012||Nikkiso Co., Ltd.||Blood purification apparatus and method for calculating a recirculation rate for the blood purification apparatus|
|US8603021||May 2, 2011||Dec 10, 2013||Gambro Uf Solutions, Inc.||Method and apparatus for ultrafiltration of blood|
|US8702638||Aug 24, 2012||Apr 22, 2014||Gambro Uf Solutions, Inc.||Method for blood withdrawal and infusion using a pressure controller|
|USRE38869 *||Sep 9, 2004||Nov 8, 2005||Chf Solutions Inc.||Extracorporeal circuit for peripheral vein fluid removal|
|DE19528907C1 *||Aug 5, 1995||Nov 7, 1996||Fresenius Ag||Haemodynamic parameter measurement equipment for extracorporeal blood circulation appts.|
|DE19541783C1 *||Nov 9, 1995||Mar 27, 1997||Fresenius Ag||Verfahren zum Betreiben einer Blutbehandlungsvorrichtung zur Ermittlung hämodynamischer Parameter während einer extrakorporalen Blutbehandlung und Vorrichtung zur Ermittlung hämodynamischer Parameter während einer extrakorporalen Blutbehandlung|
|EP0773035A2||Oct 31, 1996||May 14, 1997||Fresenius AG||Method and apparatus for determining hemodynamic variables during extracorporal blood treatment|
|EP0944362A1 *||Oct 22, 1997||Sep 29, 1999||In-Line Diagnostics Corporation||System and method for noninvasive hemodynamic measurements in hemodialysis shunts|
|EP1449549A2||Oct 17, 1997||Aug 25, 2004||GAMBRO HOSPAL (Schweiz) AG||Process for determining the recirculation of blood in a vascular access|
|EP1938847A2||Oct 31, 2002||Jul 2, 2008||Gambro Lundia AB||Method and apparatus for determining access flow|
|EP1949922A2||Jan 5, 1999||Jul 30, 2008||Fresenius Medical Care Holdings, Inc.||Method and apparatus for determining hemodialysis parameters|
|EP2198900A2||Oct 22, 1999||Jun 23, 2010||Gambro Ab||Method and device for detecting access recirculation|
|WO1996008305A1 *||Nov 18, 1994||Mar 21, 1996||Transonic Systems Inc||Blood flow measurement method in hemodialysis shunts|
|WO1998017193A1||Oct 22, 1997||Apr 30, 1998||In Line Diagnostics Corp||System and method for noninvasive hemodynamic measurements in hemodialysis shunts|
|WO1998017334A1||Oct 17, 1997||Apr 30, 1998||Hospal Ag||Method for determining the recirculation of blood in a vascular access and system for implementing same|
|WO2000018451A1||Sep 9, 1999||Apr 6, 2000||Univ Michigan||Determining blood flow rate in a vessel|
|WO2001045770A1||Dec 18, 2000||Jun 28, 2001||Hospal Ag||Device and a method for determining blood recirculation in a vascular access|
|WO2003082144A2 *||Feb 13, 2003||Oct 9, 2003||Chf Solutions Inc||Method and apparatus for an extracorporeal treatment device to control blood withdrawal and infusion|
|WO2006022099A1 *||Jul 21, 2005||Mar 2, 2006||Nikkiso Co Ltd||Blood purification apparatus|
|WO2010115621A2 *||Apr 8, 2010||Oct 14, 2010||Fresenius Medical Care Deutschland Gmbh||Device and method for measuring a blood constituent in blood for an extracorporeal blood treatment device|
|May 17, 2006||SULP||Surcharge for late payment|
Year of fee payment: 11
|May 17, 2006||FPAY||Fee payment|
Year of fee payment: 12
|Nov 30, 2005||REMI||Maintenance fee reminder mailed|
|May 6, 2002||AS||Assignment|
Owner name: QUAD-C MANAGEMENT, VIRGINIA
Free format text: RELEASE OF SECURITY INTEREST;ASSIGNOR:HEMA METRICS, INC.;REEL/FRAME:012884/0406
Effective date: 20020214
Owner name: QUAD-C MANAGEMENT 230 E. HIGH STREET CHARLOTTESVIL
Owner name: QUAD-C MANAGEMENT 230 E. HIGH STREETCHARLOTTESVILL
Free format text: RELEASE OF SECURITY INTEREST;ASSIGNOR:HEMA METRICS, INC. /AR;REEL/FRAME:012884/0406
|Sep 11, 2001||AS||Assignment|
Owner name: QUAD-C MANAGEMENT, VIRGINIA
Free format text: SECURITY AGREEMENT;ASSIGNOR:HEMA METRICS, INC.;REEL/FRAME:012153/0582
Effective date: 20010906
Owner name: QUAD-C MANAGEMENT 230 E. HIGH STREET CHARLOTTESVIL
Owner name: QUAD-C MANAGEMENT 230 E. HIGH STREETCHARLOTTESVILL
Free format text: SECURITY AGREEMENT;ASSIGNOR:HEMA METRICS, INC. /AR;REEL/FRAME:012153/0582
|Aug 28, 2001||FPAY||Fee payment|
Year of fee payment: 8
|Aug 18, 1998||AS||Assignment|
Owner name: UNIVERSITY OF MISSISSIPPI MEDICAL CENTER, MISSISSI
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:H & H CONTROL SYSTEMS INC.;REEL/FRAME:009396/0879
Effective date: 19980811
|Dec 22, 1997||AS||Assignment|
Owner name: H & H CONTROL SYSTEMS INC., MISSISSIPPI
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:HESTER, ROBERT L.;REEL/FRAME:008855/0796
Effective date: 19971015
|Sep 3, 1997||FPAY||Fee payment|
Year of fee payment: 4
|Apr 23, 1996||B1||Reexamination certificate first reexamination|
|Jun 20, 1995||RR||Request for reexamination filed|
Effective date: 19950414